The Scientist

» cancer therapeutics

Most Recent

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

The US Food and Drug Administration greenlights Roche’s Tecentriq, which blocks a protein that obstructs the immune system’s ability to fight cancer.

0 Comments

image: FDA OKs Herpesvirus to Treat Cancer

FDA OKs Herpesvirus to Treat Cancer

By | October 28, 2015

The US Food and Drug Administration’s approval of an engineered herpesvirus for the treatment of melanoma marks the first oncolytic virus to enter the market.

0 Comments

image: CAR-T Therapies Get $1 Billion Boost

CAR-T Therapies Get $1 Billion Boost

By | July 1, 2015

The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.

0 Comments

image: The CAR T-Cell Race

The CAR T-Cell Race

By | April 1, 2015

Tumor-targeting T-cell therapies are generating remarkable remissions in hard-to-beat cancers—and attracting millions of dollars of investment along the way.

2 Comments

Scientists generate tumor-targeting molecules that can be used for imaging and treatment.

0 Comments

image: Tactical Maneuvers

Tactical Maneuvers

By | June 1, 2014

Scientists are creating viruses that naturally home in on tumor cells while simultaneously boosting the body’s immune system to fight cancer.

2 Comments

image: Targeting Tumors with Viruses

Targeting Tumors with Viruses

By | June 1, 2014

Stephanie Swift discusses the strategy of fighting cancer with viruses.

0 Comments

Popular Now

  1. Scientists Activate Predatory Instinct in Mice
  2. National Academies Detail the State of Weed Science
  3. Superbug Resistant to Every Antibiotic in the U.S. Killed Nevada Woman
  4. Trumping Science: Part III
    The Nutshell Trumping Science: Part III

    Scientists criticize unconfirmed reports that President-elect Donald Trump has asked Robert Kennedy Jr., an anti-vaccine activist, to investigate vaccine safety.

RayBiotech